Shares of Aurora Cannabis Inc. ACB rallied 2.30% to $4.44 Thursday, on what proved to be an all-around dismal trading session ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced ...

Aurora Cannabis (ACB) announced the availability of medical cannabis concentrates to patients in the U.K. These products are available to ...

Aurora’s globalization strategy is paying off, and within global medical cannabis, its international revenue increased by 112%. For the second consecutive quarter, international revenue ...

Aurora Cannabis capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics, and deep regulatory knowledge to expand ...

Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event in Washington, D.C. Aurora Logo (CNW Group/Aurora Cannabis Inc.) "The opportunity ...

Aurora discovered a new source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa. Given this discovery, the company is set to develop powdery mildew-resistant plants.

EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's ...

Has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (U.K.). This launch marks the company's meaningful step in offering its proprietary ...

Aurora Cannabis Inc. closed 54.22% short of its 52-week high of $9.35, which the company reached on April 30th.

EDMONTON, AB, April 15, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the availability of ...